You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 93 No. 5, November 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prolonged Thoracic Duct Lymph Drainage

Application for Human Renal Homotransplantation

TAKAO SONODA, MD; MINATO TAKAHA, MD; TAKAMITSU KUSUNOKI, MD

AMA Arch Surg. 1966;93(5):831-833.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

USING thoracic duct lymph drainage, Cronemiller and his associates1 were able to reduce the blood urea nitrogen (BUN) level and remove edema in patients with uremia due to advanced chronic renal insufficiency. On the other hand, Dumont and Mulholland2 indicated that thoracic duct drainage was effective in reducing ascites in patients with liver cirrhosis. In the field of organ transplantation, removal of lymphocytes from the body has drawn particular attention because lymphocytes are significantly involved in antibody production. Lymphocytes can be eliminated from the body of animals in any one of the following three ways: (1) the use of antilymphocytic immune serum3-6; (2) selective irradiation by a β-emitting isotope7-10; and (3) thoracic duct lymph drainage.11,13 McGregor and Gowans11 demonstrated that chronic thoracic duct lymph drainage can reduce the rat's lymphocytes in the peripheral blood, inhibit antibody production, and prolong skin homograft survival time. Samuelson . . . [Full Text PDF of this Article]


Author Affiliations

OSAKA, JAPAN

From the Department of Urology, Osaka University Medical School, Osaka.


Footnotes

Submitted for publication Feb 18, 1966.

Reprint requests to Department of Urology, Osaka University Hospital, Osaka University Medical School, Fukushima-Ku, Osaka, Japan (Dr. Sonoda).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.